Skip to Main Content

Medtronic plc (NYSE: MDT) Securities Fraud Violations Class Action Lawsuit

View Complaint
COMPANY         Medtronic plc
COURT United States District Court for the District of Minnesota
CASE NUMBER 22-cv-02197
JUDGE Katherine Marie Menendez
CLASS PERIOD June 8, 2019 and May 25, 2022
SECURITY TYPE  Common Stock

Case Background:

A class action lawsuit was filed on behalf of those who purchased or acquired Medtronic plc (“Medtronic”) (NYSE:  MDT) securities between June 8, 2019 and May 25, 2022, inclusive (the “Class Period”)

The Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts, about the company’s business and operations by failing to disclose that: (1) Medtronic’s product quality control systems were inadequate; (2) Medtronic had failed to comply with numerous regulations regarding risk assessment, corrective and preventive action, complaint handling, device recalls, and reporting of adverse events; (3) these failures increased the risk of regulatory investigation and action; (4) as a result of the company’s misconduct, the FDA would delay the approval of additional Medtronic MiniMed devices, including the MiniMed 780G; (5) these delays in product approvals, as well as the company’s need to improve its quality control systems, would negatively affect Medtronic’s financial performance and cause it to fall further behind its competitors; and (6) as a result of the foregoing, Defendants’ statements about the company’s business, operations, and prospects lacked a reasonable basis.

Current Status of Case:

On October 21, 2024, Lead Plaintiff filed an Amended Complaint. Defendants filed a Motion to Dismiss the Amended Complaint on December 6, 2024 and the parties are currently briefing that Motion.  This action is ongoing.  

If you wish to discuss this action or have any questions concerning this notice or your rights or interests with respect to these matters, please contact Kessler Topaz Meltzer & Check, LLP:  Jonathan Naji, Esq. (484) 270-1453 or via e-mail at info@ktmc.com.  If you would like additional information about the suit, please click on the link "Submit Your Information" above and fill out the form as promptly as possible.

Please complete this form relating to your transactions for Medtronic plc (“Medtronic”) (NYSE:  MDT) securities between June 8, 2019 and May 25, 2022, inclusive (the “Class Period”).

You may also contact Jonathan Naji, Esq. (484) 270-1453; or you may submit your information via email at info@ktmc.com; or you may click here to print a PDF of this form.

SUBMIT YOUR INFORMATION
* Denotes required field
Date
# of Shares
Price per Share
Date
Principal Amount
Amount Paid
Series or CUSIP
Date
# of Contracts
Price per Contract
Exercise Price
Expiration Date
Did you purchase shares of Medtronic plc prior to the Class Period?
Are you a current or former employee of Medtronic plc?
The submission of this form does not create an attorney-client relationship, nor an obligation on the part of Kessler Topaz or you to file a lead plaintiff motion in this matter. Any information you submit will be maintained as confidential. If Kessler Topaz, in its sole discretion, believes that you might be an appropriate lead plaintiff candidate, Kessler Topaz will contact you to discuss the matter and whether to establish an attorney client relationship. By signing this form you are authorizing us to contact you regarding this case and/or future cases.
I agree to the KTMC disclaimer
I would like to receive new case alerts by email